Skip to main content
. 2022 Aug 12;2(5):oeac053. doi: 10.1093/ehjopen/oeac053

Table 2.

Cardiac magnetic resonance–derived morphological and functional infarct characterization

Variable All patients MACE No MACE P-value
Myocardial infarction
Infarct size (%) 13.4 (5.4–21.8) 20.4 (9.8–29.0) 13.1 (5.3–21.4) 0.001
Microvascular obstruction (%) 0.36 (0.00–2.00) 0.88 (0.00–2.86) 0.33 (0.00–1.93) 0.041
Area at risk (%) 29.4 (20.3–42.6) 33.6 (24.2–45.9) 29.3 (20.3–42.4) 0.068
Myocardial salvage index 54.7 (33.7–74.7) 44.5 (23.4–69.1) 55.5 (35.0–74.7) 0.024
Ventricular function
LVEF (%) 50.6 (43.5–57.6) 40.0 (33.1–52.4) 51.0 (44.3–57.6) <0.001
LV GLS (%) –16.4 (–12.4, –20.1) –11.6 (–8.3, –17.1) –16.6 (–12.9, –20.3) <0.001
Atrial function
LA Es (%) 20.9 (16.3–25.8) 16.2 (11.6–21.3) 21.2 (16.7–26.2) <0.001
LAEF (%) 53.3 (46.5–59.3) 44.2 (35.2–52.0) 53.8 (47.1–59.5) <0.001
LA LAS (%) 17.5 (14.5–20.6) 12.7 (9.3–17.4) 17.7 (14.8–20.8) <0.001
LA LAS90 (%) 19.9 (16.1–23.6) 14.7 (10.6–19.0) 20.2 (16.6–23.9) <0.001

Data presented as median with associated interquartile range. P-values were calculated for the comparison between patients with and without MACE using the Mann–Whitney U test. Numbers in bold indicate statistical significance.

LV, left-ventricle; EF, ejection fraction; GLS, global longitudinal strain; LA, left atrium; Es, reservoir function; LAS, long-axis strain.